Continue Reading Below
Shares of Rite Aid Corporation (NYSE: RAD) took a dive today after the company's agreement to sell a chunk of its stores to Walgreens Boots Alliance (NASDAQ: WBA) was finally approved by the Federal Trade Commission but with fewer stores than previously stipulated.
Walgreens will now take over 254 fewer stores, or 1,932 in total, and pay $800 million less, or $4.38 billion. The deal will leave Rite Aid with about 2,600 stores. As of 11:18 a.m. EDT, Rite Aid's stock was down 9.2%, while Walgreens' was off 1.8%.
News that the feds finally approved a deal between the two drugstore chains after two years of negotiations would seem to be a good thing for Rite Aid, but the country's No. 3 pharmacy chain is actually getting a lower price per store in this agreement.
Walgreens is paying $2.27 million for each of the 1,932 stores, which includes three distribution centers and related inventory. In the previous agreement made in June, Rite Aid was going to sell 2,186 at an average price of $2.37 billion. The slimmed-down deal also gives Rite Aid less money to pay down its substantial debt burden and invest in its remaining stores. Walgreens investors may be disappointed that it's getting fewer stores than it would have. Originally, Walgreens had sought to acquire Rite Aid outright.
Continue Reading Below
Rite Aid CEO John Standley said the deal would result in "a compelling and more profitable store footprint in key markets, enhanced purchasing capabilities and a stronger balance sheet and improved financial flexibility."
Transfer of the stores will begin in October and is expected to be completed by the spring of next year. From there, the hard work of repairing the business will start. Most of the cash influx will be used to pay off its $7.2 billion debt burden, and Rite Aid should benefit from a part of the agreement that allows it to purchase generic drugs through Walgreens. Expect Rite Aid shares to remain volatile through the transition.
10 stocks we like better than Rite Aid
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Rite Aid wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of September 5, 2017